Skip to content
Screener

Bicara Therapeutics BCAX Business Segments — Professional fees

Similar metrics at other companies

SLM logo
SLMReportable Segment — Professional fees
$28.77M+41.6%
Fulton Financial logo
FULTReportable Segment — Professional fees
$1.37M-49.4%
LPR
LPROReportable Segment — Professional fees
$2.51M+9.2%
comScore logo
SCORReportable Segment — Professional fees
$5.59M+14.4%
Tradeweb Markets Inc. logo
TWReportable Segment — Professional fees
$12.77M-9.8%
ARD
ARDTReportable Segment — Professional fees
$122.53M+18.0%

Other financials

Income statement

See full
Operating income-$60.2M-44.2%
Net income-$56.2M-52.6%
EPS (diluted)-$0.93-36.8%

Balance sheet

See full
Cash & equivalents$323.5M-30.0%
Total debt$1.4M+144%
Total equity$514.0M+12.0%
Total assets$553.6M+15.8%

Cash flow

See full
Operating cash flow-$37.5M-33.5%
CapEx$60.0K
Free cash flow-$37.6M-33.7%

Valuation

See full
Market cap$1.81B+217%
Enterprise value$1.49B+1,000%

Returns & leverage

See full
Return on equity-32.3%
Debt / equity0.0×
Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfessionalFees.

The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033429
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Research601556
Total research and development47,50034,333
General and administrative personnel costs (including stock-based compensation)7,9634,832
Professional fees3,5601,504
Facility costs, IT, office expense and other1,2191,119
Total general and administrative expenses12,7427,455
Total operating expenses60,24241,788
Operating loss(60,242)(41,788)

Item 1. Financial Statements (Unaudited)

FAQ

What is Bicara Therapeutics's business segments — professional fees?
Bicara Therapeutics (BCAX) reported business segments — professional fees of $3.56M in Q1 2026.
How has Bicara Therapeutics's business segments — professional fees changed year-over-year?
Bicara Therapeutics's business segments — professional fees increased by 136.7% year-over-year, from $1.5M to $3.56M.
What is the long-term trend for Bicara Therapeutics's business segments — professional fees?
Over 2 years (2023 to 2025), Bicara Therapeutics's business segments — professional fees has grown at a 69.3% compound annual growth rate (CAGR), from $2.06M to $5.91M.
What does business segments — professional fees mean?
Represents payments made to external consultants, legal counsel, auditors, and other professional service providers. These costs are essential for maintaining corporate governance, regulatory compliance, and specialized operational support.

Ask your AI about Bicara Therapeutics's business segments — professional fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude